Tevogen Bio Holdings rebrands as Tevogen Inc
Top Biotech Gainers: GOSS To File Seralutinib NDA In Sep, OMER Gains On AZN's Loss, FBRX Acquired
Tevogen Bio announces annual shareholder meeting
Tevogen Bio Announces 2026 Annual Meeting of Stockholders | TVGN Stock News
Tevogen Announces Formation of a Healthcare Services Initiative | TVGN Stock News
Tevogen Advances Strategic Acquisition Plans With Potential To Add $100 Million In Annual Revenue